Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Masuhara

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Gastroenterology|July 11, 1998
Fulminant hepatitis complicated by small intestine infection and massive hemorrhageH Tamura, S Yamashita, N Kusano, et al.
Oncogene|November 12, 1998
CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cellsR Suzuki, H Sakamoto, H Yasukawa, et al.
The EMBO Journal|March 4, 1999
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loopH Yasukawa, H Misawa, H Sakamoto, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
Cloning and characterization of novel CIS family genesM Masuhara, H Sakamoto, A Matsumoto, et al.
Blood|August 26, 1998
A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferonsH Sakamoto, H Yasukawa, M Masuhara, et al.
Journal of Gastroenterology|June 5, 2001
HBV-related fulminant hepatic failure: successful intensive medical therapy in a candidate for liver transplantationM Masuhara, T Yagawa, M Aoyagi, et al.
Nature|June 26, 1997
A new protein containing an SH2 domain that inhibits JAK kinasesT A Endo, M Masuhara, M Yokouchi, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Gastroenterology|July 11, 1998
Fulminant hepatitis complicated by small intestine infection and massive hemorrhageH Tamura, S Yamashita, N Kusano, et al.
Oncogene|November 12, 1998
CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cellsR Suzuki, H Sakamoto, H Yasukawa, et al.
The EMBO Journal|March 4, 1999
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loopH Yasukawa, H Misawa, H Sakamoto, et al.
Biochemical and Biophysical Research Communications|November 5, 1997
Cloning and characterization of novel CIS family genesM Masuhara, H Sakamoto, A Matsumoto, et al.
Blood|August 26, 1998
A Janus kinase inhibitor, JAB, is an interferon-gamma-inducible gene and confers resistance to interferonsH Sakamoto, H Yasukawa, M Masuhara, et al.
Journal of Gastroenterology|June 5, 2001
HBV-related fulminant hepatic failure: successful intensive medical therapy in a candidate for liver transplantationM Masuhara, T Yagawa, M Aoyagi, et al.
Nature|June 26, 1997
A new protein containing an SH2 domain that inhibits JAK kinasesT A Endo, M Masuhara, M Yokouchi, et al.
Pageof 3